Jorg P. Muller
Jena, TH 07745, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Targeting MCL-1 and MAPK overcomes venetoclax resistance in FLT3-ITD-positive AML cells harbouring activating PTPN11 (SHP-2) mutations.
Journal: British journal of haematology
Published: August 19, 2025
Targeting Oncogenic Activity and Signalling of Mutant Receptor Tyrosine Kinase FLT3.
Journal: Cancers
Published: July 25, 2025
Age-dependent role of histone deacetylase Sirt7 on haematopoiesis.
Journal: Stem cells (Dayton, Ohio)
Published: July 23, 2025
Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression.
Journal: BMC cancer
Published: February 11, 2025
CRISPR/Cas9-Mediated Modification of PTP Expression.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 26, 2023
Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD.
Journal: Frontiers in oncology
Published: August 12, 2022
PI3Kγ is a novel regulator of TNFα signaling in the human colon cell line HT29/B6.
Journal: Annals of the New York Academy of Sciences
Published: June 21, 2022
Publisher Correction: SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders.
Journal: Leukemia
Published: November 17, 2021
PI3Kγ Mediates Microglial Proliferation and Cell Viability via ROS.
Journal: Cells
Published: July 19, 2021
Biocompatibility, uptake and subcellular localization of bacterial magnetosomes in mammalian cells.
Journal: Nanoscale advances
Published: December 29, 2020
Last Updated: 09/26/2026